Patents by Inventor Jeffrey Axelrod

Jeffrey Axelrod has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11946044
    Abstract: Disclosed herein are methods for isolating DNA, such as cell-free DNA (cfDNA) or DNA from a tissue sample, e.g., in which the DNA is partitioned into hypermethylated and hypomethylated partitions. After differential tagging of the partitions, portions of the hypomethylated partition are pooled with the hypermethylated partition or pooled separately. Epigenetic and sequence-variable target regions are captured from the pool comprising DNA from the hypermethylated and hypomethylated partitions, and sequence-variable target regions are captured from the pool comprising DNA from the hypomethylated partition. This approach can reduce costs and/or bandwidth by limiting sequencing of epigenetic target regions from the hypomethylated partition, which may be less informative than other DNA.
    Type: Grant
    Filed: July 29, 2021
    Date of Patent: April 2, 2024
    Assignee: Guardant Health, Inc.
    Inventors: Ariel Jaimovich, Sven Jeffrey Duenwald, Peter Vilem Grauman, Yupeng He, Charbel Said Eid, Haley Dara Axelrod
  • Publication number: 20230277550
    Abstract: Abstract: The invention therefore provides methods of treating a respiratory disease characterized by mucus hyper-secretion comprising administering to a human patient in need of such treatment a gamma secretase inhibitor (GSI), wherein the administration of a GSI is effective in reducing mucus in such patient’s lungs or inhibiting mucus accumulation in said patient’s lungs. In some embodiments, the methods of the invention are effective in treating a respiratory disease selected from the group consisting of cystic fibrosis, chronic obstructive pulmonary disease, primary ciliary dyskinesis, chronic bronchitis, asthma, idiopathic and secondary bronchiectasis, bronchiolitis obliterans, idiopathic pulmonary fibrosis and other fibrotic lung disorders, respiratory infection including exacerbations in chronic respiratory disorders, and mucus accumulation in response to acute infection.
    Type: Application
    Filed: August 19, 2021
    Publication date: September 7, 2023
    Inventors: Jeffrey Axelrod, Carlos Milla, Eszter Vladar
  • Patent number: 7590972
    Abstract: This invention relates to a business application development and execution environment that recognizes and supports various development and user roles. Aspects of the method and system are adapted to builders, assemblers, power users and end users.
    Type: Grant
    Filed: October 28, 2004
    Date of Patent: September 15, 2009
    Assignee: Cogency Software, Inc.
    Inventors: Jeffrey Axelrod, Sameer Shalaby, Jay Gitterman, William Herndon, Jie Deng
  • Publication number: 20060095276
    Abstract: This invention relates to a business application development and execution environment that recognizes and supports various development and user roles. Aspects of the method and system are adapted to builders, assemblers, power users and end users.
    Type: Application
    Filed: October 28, 2004
    Publication date: May 4, 2006
    Applicant: Cogency Software, Inc.
    Inventors: Jeffrey Axelrod, Sameer Shalaby, Jay Gitterman, William Herndon, Jie Deng